Depo-Provera Lawsuit in New York

What New York residents should know

New York residents have two possible litigation settings. Some cases are proceeding in New York state court, while federal cases are centralized in MDL-3140 before Judge M. Casey Rodgers in the Northern District of Florida. Each plaintiff keeps an individual claim.

The litigation alleges that Depo-Provera can cause intracranial meningioma and that warnings were inadequate. Pfizer and the Pharmacia entities dispute the allegations.

How are New York and federal Depo-Provera cases coordinated?

Federal Case Management Order No. 11 states that the March 6, 2026 case-management conference was held jointly with New York Justice Sabrina Kraus and Delaware Judge Kathleen Vavala. The order reported 95 New York state cases involving 104 plaintiffs at that time. Joint court management is intended to reduce conflicting schedules and duplicative work; it does not combine all plaintiffs into a class action or decide whether any claim will succeed.

Sources: N.D. Florida — MDL-3140 Case Management Order No. 11; N.D. Florida — Depo-Provera MDL-3140; New York C.P.L.R. 214 — personal-injury limitations period.

What facts are commonly reviewed in a New York Depo-Provera claim?

There is no automatic qualification rule. A review generally compares documented medication use with the diagnosis and filing timeline.

• Injection, prescription, clinic, pharmacy, and insurance records identifying Depo-Provera and dates of use.
• MRI or other brain-imaging reports, neurology notes, pathology, surgery, radiation, and monitoring records.
• The timing of use, symptoms, diagnosis, and treatment.
• Facts that determine which court and filing-deadline rules apply.

What records support Depo-Provera claims in New York?

• Prescription, pharmacy, OB/GYN, clinic, insurance, or injection records showing Depo-Provera use and dates.
• Brain imaging reports, neurology notes, neurosurgery records, pathology reports, radiation records, and monitoring history.
• Records showing symptoms, diagnosis date, tumor type, surgery, radiation, disability, or ongoing neurological effects.
• Provider names, appointment histories, patient portal downloads, and documents that help reconstruct injection timing.

What exposure and legal context matter in New York?

New York residents may have received Depo-Provera injections through OB/GYN offices, public health clinics, primary-care practices, pharmacies, or other clinical settings.

Where are New York Depo-Provera cases handled?

Living in New York does not necessarily mean the case will be filed only in New York. Claims may be evaluated by national firms, filed in federal court, coordinated through MDL proceedings, or handled through another legal process.

Federal courts in New York

• Northern District of New York
• Southern District of New York
• Eastern District of New York
• Western District of New York

What is the filing deadline for Depo-Provera lawsuits in New York?

For a New York resident researching Depo-Provera claims, the starting point is usually New York's general personal injury period: 3 years under N.Y. C.P.L.R. 214. That is only a starting point, not a final legal deadline for every person.

The real filing deadline can depend on diagnosis date, when the injury and possible cause were discovered, exposure location, wrongful-death issues, prior claim paperwork, and whether the case is filed directly, transferred to an MDL, or handled through another process.

Discovery-rule note: For injuries caused by the latent effects of exposure to a substance, C.P.L.R. 214-c generally measures the three-year period from discovery of the injury, subject to additional requirements and exceptions.

How long do New York residents have to file?

New York's personal injury statute of limitations applicable to product liability claims is 3 years (N.Y. C.P.L.R. 214). Accrual timing, tolling, and repose periods can still change the real deadline in an individual case.

• Filing period: 3 years — N.Y. C.P.L.R. 214.
• Discovery rule: For injuries caused by the latent effects of exposure to a substance, C.P.L.R. 214-c generally measures the three-year period from discovery of the injury, subject to additional requirements and exceptions.

Because the controlling deadline depends on diagnosis date, discovery facts, exposure history, wrongful-death rules, and how the claim is filed, only a licensed attorney can confirm the deadline that applies to a specific situation. This page is general legal information, not legal advice.

What should New York residents ask a lawyer?

• What injection records do you need to evaluate my Depo-Provera use history?
• How do meningioma diagnosis date, imaging, surgery, radiation, or monitoring records affect review?
• Could the pending expert-hearing and preemption rulings affect my claim?
• How do state filing deadlines apply to my diagnosis and discovery timeline?
• Would my claim be handled locally, nationally, or through the MDL?
• Are there upfront costs?